Form 4 for APYX Apyx Medical Corp
Accepted 2026-03-17 00:00:00 ET · period of report 2026-03-15 · accession 0001493152-26-010632 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-17 | 2026-03-15 | APYX | CITRONOWICZ MOSHE | SVP | M - OptEx | $1.80 | +37.0K | 493.5K | +8% | +$66.6K |
| D | 2026-03-17 | 2026-03-15 | APYX | CITRONOWICZ MOSHE | SVP | M - OptEx | $0.00 | -37.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-15 | M | A | 37,000 | $1.80 | 493,504 | D | — | — | |
| 2 | Derivative | Stock option (right to buy) | 2026-03-15 | M | D | 37,000 | $0.00 | 0 | D | $1.80 · — to 2036-03-16 | 37,000 Common Stock | (F1) On March 15, 2026, the Reporting Person exercised his stock option awarded on March 16, 2016, to purchase 37,000 shares of the Issuer's common stock at a price of $1.80 per share pursuant to Issuer's 2015 Share Incentive Plan. |